048260 — OsstemImplant Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Market Cap
KR₩3tn
Enterprise Value
KR₩3tn
Revenue
KR₩1tn

Annual income statement for OsstemImplant Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	460,147	565,043	631,596	824,566	1,053,472
Cost of Revenue
Gross Profit	258,547	319,137	378,199	496,324	670,488
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	431,659	524,278	534,956	683,962	820,694
Operating Profit	28,488	40,765	96,640	140,603	232,778
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	18,024	29,330	103,059	34,988	202,238
Provision for Income Taxes
Net Income After Taxes	6,256	-21,960	103,534	23,411	144,201
Minority Interest
Net Income Before Extraordinary Items
Net Income	12,691	-16,262	107,046	25,012	138,137
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	12,691	-16,262	107,046	25,012	138,137
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	10,255	-10,926	75,193	16,198	94,282
Dividends per Share